Provided by Tiger Trade Technology Pte. Ltd.

Astrana Health

18.59
-2.5100-11.90%
Pre-market: 18.700.1100+0.59%07:01 EST
Volume:779.11K
Turnover:14.92M
Market Cap:932.39M
PE:95.15
High:21.21
Open:21.05
Low:18.56
Close:21.10
52wk High:39.97
52wk Low:18.56
Shares:50.16M
Float Shares:37.78M
Volume Ratio:1.25
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1954
EPS(LYR):0.9000
ROE:1.83%
ROA:2.88%
PB:1.20
PE(LYR):20.66

Loading ...

Astrana Health Is Maintained at Buy by BTIG

Dow Jones
·
Feb 02

U.S. RESEARCH ROUNDUP-Air Products, Chevron, UnitedHealth

Reuters
·
Feb 02

Astrana Health (ASTH) Is Down 16.3% After Modest 2027 Medicare Advantage Update Proposal - What's Changed

Simply Wall St.
·
Jan 31

Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst

Benzinga_recent_news
·
Jan 28

Astrana Health: Market Overreaction to CMS Risk-Adjustment Proposal Creates a Buy Opportunity

TIPRANKS
·
Jan 28

Astrana Health Inc. to Release Fourth Quarter and Year-End Financial Results

Reuters
·
Jan 26

Assessing Astrana Health (ASTH) Valuation After Mixed Share Price Momentum And A High P/E Multiple

Simply Wall St.
·
Jan 14

BTIG Sticks to Their Buy Rating for Astrana Health (ASTH)

TIPRANKS
·
Jan 13

Astrana Health Updates Investor Presentation Highlighting National Expansion

TIPRANKS
·
Jan 13

BofA Adjusts Price Target on Astrana Health to $33 From $40, Maintains Buy Rating

MT Newswires Live
·
Jan 06

Needham Initiates Astrana Health With Buy Rating, $28 Price Target

MT Newswires Live
·
Dec 12, 2025

Astrana Health Initiated at Buy by Needham

Dow Jones
·
Dec 12, 2025

Astrana Health Is Maintained at Buy by Jefferies

Dow Jones
·
Nov 26, 2025

Astrana Health price target lowered to $37 from $44 at Jefferies

TIPRANKS
·
Nov 26, 2025

Astrana Health Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Nov 24, 2025

Why Astrana Health (ASTH) Cut Guidance Despite Strong Revenue Growth After Prospect Integration

Simply Wall St.
·
Nov 21, 2025

Astrana Health Inc Q3 Revenue USD 897.73 Million Vs. IBES Estimate USD 952.8 Million

Reuters
·
Nov 20, 2025

Astrana Health (ASTH) Is Down 28.1% After Revenue Soars but Profit Drops Sharply in Q3

Simply Wall St.
·
Nov 12, 2025

Truist Lowers Price Target on Astrana Health to $37 From $46, Keeps Buy Rating

MT Newswires Live
·
Nov 12, 2025

Truist Financial Sticks to Its Buy Rating for Astrana Health (ASTH)

TIPRANKS
·
Nov 12, 2025